-
Editorial
-
- Core protein inhibitors: Opportunities and challenges at the forefront of hepatitis B cure
-
Hae Lim Lee1,2, Jeong Won Jang1,2
-
1Division of Hepatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
2The Catholic University Liver Research Center, Seoul, Republic of Korea
- Corresponding author: Jeong Won Jang ,Tel: +82-2-2258-6015, Fax: +82-2-3481-4025, Email: garden@catholic.ac.kr
- Received: May 9, 2024; Accepted: May 13, 2024.